A01K 2217/054
Inducing loss of function
Official title: inducing loss of function
A01K2217/054 (Inducing loss of function) appears on 185 US grants and 381 published applications in this corpus.
Search patents in A01K- Granted patents
- 185
- Published applications
- 381
- Assignees
- 238
- Inventors
- 749
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 2 |
| 2004 | 1 | 3 |
| 2005 | 0 | 14 |
| 2006 | 0 | 13 |
| 2007 | 0 | 12 |
| 2008 | 4 | 22 |
| 2009 | 4 | 22 |
| 2010 | 5 | 24 |
| 2011 | 9 | 25 |
| 2012 | 11 | 19 |
| 2013 | 9 | 14 |
| 2014 | 14 | 12 |
| 2015 | 14 | 16 |
| 2016 | 16 | 18 |
| 2017 | 10 | 17 |
| 2018 | 13 | 22 |
| 2019 | 10 | 21 |
| 2020 | 5 | 14 |
| 2021 | 13 | 18 |
| 2022 | 9 | 22 |
| 2023 | 14 | 11 |
| 2024 | 7 | 18 |
| 2025 | 9 | 11 |
| 2026 | 7 | 11 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Method for constructing murine model with mutations in csflr gene and application thereof14 Jul 2026US 12,677,811 B2Beijing Tiantan Hospital, Capital Medical University
- Methods of treatment with aminolevulinic acid synthase 2 (ALAS2) modulators30 Jun 2026US 12,667,087 B2Agios Pharmaceuticals, Inc.
- Endonuclease sexing and sterilization in insects12 May 2026US 12,622,419 B2The Regents of the University of California
- Compositions and methods for determining genetic polymorphisms in the TMEM216 gene24 Feb 2026US 12,559,798 B2The Regents of the University of California
- Compositions and methods for determining genetic polymorphisms in the tmem216 gene24 Sep 2026US 2026/0286437 A1The Regents of the University of California
- Woolly mammoth specific gene variants and compositions comprising same17 Sep 2026US 2026/0274907 A1Colossal Biosciences Inc.
- Method for knocking out bovine fbxo40 gene and application thereof27 Aug 2026US 2026/0248115 A1Beijing Forestry University
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- Methods and compositions for modulating gene expression6 Aug 2026US 2026/0226464 A1Flagship Pioneering Innovations V, Inc.
Most cited
By later US patents
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015
- Therapeutic uses of inhibitors of RTP80198US 7,741,299 B2Quark Pharmaceuticals, Inc. · 2010
- Use of AIM3 acting as a tumor suppressor88US 7,902,165 B2Seoul National University Industry Foundation · 2011
- Polyconjugates for in vivo delivery of polynucleotides74US 8,137,695 B2Arrowhead Madison Inc. · 2012
- Polyconjugates for in vivo delivery of polynucleotides69US 8,658,211 B2Arrowhead Madison Inc. · 2014